{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:59:26Z","timestamp":1791874766894,"version":"4.3.4"},"reference-count":284,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Verona (FFO Grants)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Flaviviruses cause numerous pathologies in humans across a broad clinical spectrum with potentially severe clinical manifestations, including hemorrhagic and neurological disorders. Among human flaviviruses, some viral proteins show high conservation and are good candidates as targets for drug design. From an epidemiological point of view, flaviviruses cause more than 400 million cases of infection worldwide each year. In particular, the Yellow Fever, dengue, West Nile, and Zika viruses have high morbidity and mortality\u2014about an estimated 20,000 deaths per year. As they depend on human vectors, they have expanded their geographical range in recent years due to altered climatic and social conditions. Despite these epidemiological and clinical premises, there are limited antiviral treatments for these infections. In this review, we describe the major compounds that are currently under evaluation for the treatment of flavivirus infections and the challenges faced during clinical trials, outlining their mechanisms of action in order to present an overview of ongoing studies. According to our review, the absence of approved antivirals for flaviviruses led to in vitro and in vivo experiments aimed at identifying compounds that can interfere with one or more viral cycle steps. Still, the currently unavailability of approved antivirals poses a significant public health issue.<\/jats:p>","DOI":"10.3390\/microorganisms11102427","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T05:55:54Z","timestamp":1695880554000},"page":"2427","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Vector-Transmitted Flaviviruses: An Antiviral Molecules Overview"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1373-7533","authenticated-orcid":false,"given":"Erica","family":"Diani","sequence":"first","affiliation":[{"name":"Department of Diagnostic and Public Health, Microbiology Section, University of Verona, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1044-3109","authenticated-orcid":false,"given":"Anna","family":"Lagni","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Public Health, Microbiology Section, University of Verona, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5746-3810","authenticated-orcid":false,"given":"Virginia","family":"Lotti","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Public Health, Microbiology Section, University of Verona, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil","family":"Tonon","sequence":"additional","affiliation":[{"name":"Unit of Microbiology, Azienda Ospedaliera Universitaria Integrata Verona, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5189-8867","authenticated-orcid":false,"given":"Riccardo","family":"Cecchetto","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Public Health, Microbiology Section, University of Verona, 37134 Verona, Italy"},{"name":"Unit of Microbiology, Azienda Ospedaliera Universitaria Integrata Verona, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Gibellini","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Public Health, Microbiology Section, University of Verona, 37134 Verona, Italy"},{"name":"Unit of Microbiology, Azienda Ospedaliera Universitaria Integrata Verona, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"197770","DOI":"10.1016\/j.virusres.2019.197770","article-title":"Flavivirus Infection-A Review of Immunopathogenesis, Immunological Response, and Immunodiagnosis","volume":"274","author":"Chong","year":"2019","journal-title":"Virus Res."},{"key":"ref_2","unstructured":"(2023, September 04). Dengue Worldwide Overview. Available online: https:\/\/www.ecdc.europa.eu\/en\/dengue-monthly."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41586-018-0446-y","article-title":"The Emergence of Zika Virus and Its New Clinical Syndromes","volume":"560","author":"Pierson","year":"2018","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.3390\/v5123088","article-title":"West Nile Virus in the United States\u2014A Historical Perspective","volume":"5","author":"Roehrig","year":"2013","journal-title":"Viruses"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40506-023-00263-w","article-title":"Dengue: Update on Clinically Relevant Therapeutic Strategies and Vaccines","volume":"15","author":"Kala","year":"2023","journal-title":"Curr. Treat. Options Infect. Dis."},{"key":"ref_6","unstructured":"(2023, September 08). Epidemiological Update-Dengue, Chikungunya and Zika-10 June 2023-PAHO\/WHO | Pan American Health Organization. Available online: https:\/\/www.paho.org\/en\/documents\/epidemiological-update-dengue-chikungunya-and-zika-10-june-2023."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3201\/eid2401.171331","article-title":"Postmortem Findings in Patient with Guillain-Barr\u00e9 Syndrome and Zika Virus Infection-Volume 24, Number 1\u2014January 2018-Emerging Infectious Diseases Journal-CDC","volume":"24","author":"Dirlikov","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41564-020-0714-0","article-title":"The Continued Threat of Emerging Flaviviruses","volume":"5","author":"Pierson","year":"2020","journal-title":"Nat. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-10-8727-1_1","article-title":"Arboviruses: A Family on the Move","volume":"1062","author":"Young","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1146\/annurev-virology-110615-035630","article-title":"Climate Change and the Arboviruses: Lessons from the Evolution of the Dengue and Yellow Fever Viruses","volume":"3","author":"Tabachnick","year":"2016","journal-title":"Annu. Rev. Virol."},{"key":"ref_11","unstructured":"CDC (2022). Tickborne Diseases of the United States, a Reference Manual for Healthcare Providers."},{"key":"ref_12","unstructured":"(2023, September 04). World\u2019s Most Vulnerable Countries Lack the Capacity to Respond to a Global Pandemic Credit: MFD\/Elyas Alwazir | Office of the High Representative for the Least Developed Countries, Landlocked Developing Countries and Small Island Developing States. Available online: https:\/\/www.un.org\/ohrlls\/news\/world\u2019s-most-vulnerable-countries-lack-capacity-respond-global-pandemic-credit-mfdelyas-alwazir."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41594-017-0010-8","article-title":"Structural Biology of Zika Virus and Other Flaviviruses","volume":"25","author":"Hasan","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_14","unstructured":"King, A.M.Q., Adams, M.J., Carstens, E.B., and Lefkowitz, E.J. (2012). Virus Taxonomy Classification and Nomenclature of Viruses Ninth Report of the International Committee on Taxonomy of Viruses, Academic Press."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bbrc.2017.01.041","article-title":"Sequence, Structure and Function Relationships in Flaviviruses as Assessed by Evolutive Aspects of Its Conserved Non-Structural Protein Domains","volume":"492","author":"Pedersolli","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.antiviral.2013.03.008","article-title":"The Flavivirus NS1 Protein: Molecular and Structural Biology, Immunology, Role in Pathogenesis and Application as a Diagnostic Biomarker","volume":"98","author":"Muller","year":"2013","journal-title":"Antivir. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e1688","DOI":"10.1002\/wrna.1688","article-title":"Conserved Motifs in the Flavivirus NS3 RNA Helicase Enzyme","volume":"13","author":"McCullagh","year":"2022","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13567-021-00966-2","article-title":"Structure and Function of Capsid Protein in Flavivirus Infection and Its Applications in the Development of Vaccines and Therapeutics","volume":"52","author":"Zhang","year":"2021","journal-title":"Vet. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.3389\/fimmu.2018.02180","article-title":"Flavivirus Receptors: Diversity, Identity, and Cell Entry","volume":"9","author":"Laureti","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12985-021-01611-2","article-title":"The Key Amino Acids of E Protein Involved in Early Flavivirus Infection: Viral Entry","volume":"18","author":"Hu","year":"2021","journal-title":"Virol. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1242\/jcs.043042","article-title":"Recruitment of Vimentin to the Cell Surface by \u03923 Integrin and Plectin Mediates Adhesion Strength","volume":"122","author":"Bhattacharya","year":"2009","journal-title":"J. Cell Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.rvsc.2016.12.007","article-title":"Integrin Av\u03b23 Promotes Infection by Japanese Encephalitis Virus","volume":"111","author":"Fan","year":"2017","journal-title":"Res. Vet. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"54533","DOI":"10.1074\/jbc.M410208200","article-title":"Interaction of West Nile Virus with Av\u03b23 Integrin Mediates Virus Entry into Cells","volume":"279","author":"Chu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.stem.2019.11.016","article-title":"Zika Virus Targets Glioblastoma Stem Cells through a SOX2-Integrin Av\u03b25 Axis","volume":"26","author":"Zhu","year":"2020","journal-title":"Cell Stem Cell"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Miller, J.L., DeWet, B.J.M., Martinez-Pomares, L., Radcliffe, C.M., Dwek, R.A., Rudd, P.M., and Gordon, S. (2008). The Mannose Receptor Mediates Dengue Virus Infection of Macrophages. PLoS Pathog., 4.","DOI":"10.1371\/annotation\/98b92fca-fa6e-4bf3-9b39-13b66b640476"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Chen, S.T., Liu, R.S., Wu, M.F., Lin, Y.L., Chen, S.Y., Tan, D.T.W., Chou, T.Y., Tsai, I.S., Li, L., and Hsieh, S.L. (2012). CLEC5A Regulates Japanese Encephalitis Virus-Induced Neuroinflammation and Lethality. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002655"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2010.07.038","article-title":"A C-Type Lectin Collaborates with a CD45 Phosphatase Homolog to Facilitate West Nile Virus Infection of Mosquitoes","volume":"142","author":"Cheng","year":"2010","journal-title":"Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"37183","DOI":"10.1074\/jbc.M605429200","article-title":"The Location of Asparagine-Linked Glycans on West Nile Virions Controls Their Interactions with CD209 (Dendritic Cell-Specific ICAM-3 Grabbing Nonintegrin)","volume":"281","author":"Davis","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/JVI.80.3.1290-1301.2006","article-title":"West Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular Attachment and Infection","volume":"80","author":"Davis","year":"2006","journal-title":"J. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.chom.2012.08.009","article-title":"The TIM and TAM Families of Phosphatidylserine Receptors Mediate Dengue Virus Entry","volume":"12","author":"Meertens","year":"2012","journal-title":"Cell Host Microbe"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Jemielity, S., Wang, J.J., Chan, Y.K., Ahmed, A.A., Li, W., Monahan, S., Bu, X., Farzan, M., Freeman, G.J., and Umetsu, D.T. (2013). TIM-Family Proteins Promote Infection of Multiple Enveloped Viruses through Virion-Associated Phosphatidylserine. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003232"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.1128\/JVI.00354-15","article-title":"Biology of Zika Virus Infection in Human Skin Cells","volume":"89","author":"Hamel","year":"2015","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"14682","DOI":"10.1073\/pnas.1508095112","article-title":"Virion-Associated Phosphatidylethanolamine Promotes TIM1-Mediated Infection by Ebola, Dengue, and West Nile Viruses","volume":"112","author":"Richard","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.virol.2015.11.006","article-title":"DC-SIGN as an Attachment Factor Mediates Japanese Encephalitis Virus Infection of Human Dendritic Cells via Interaction with a Single High-Mannose Residue of Viral E Glycoprotein","volume":"488","author":"Wang","year":"2016","journal-title":"Virology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/tra.12469","article-title":"Beyond Attachment: Roles of DC-SIGN in Dengue Virus Infection","volume":"18","author":"Liu","year":"2017","journal-title":"Traffic"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.antiviral.2010.09.002","article-title":"Antiviral Activity of Chondroitin Sulphate E Targeting Dengue Virus Envelope Protein","volume":"88","author":"Kato","year":"2010","journal-title":"Antivir. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/jb\/mvj067","article-title":"Identification and Characterization of Carbohydrate Molecules in Mammalian Cells Recognized by Dengue Virus Type 2","volume":"139","author":"Aoki","year":"2006","journal-title":"J. Biochem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1053\/jhep.2000.18713","article-title":"Heparan Sulfate Proteoglycans Initiate Dengue Virus Infection of Hepatocytes","volume":"32","author":"Hilgard","year":"2000","journal-title":"Hepatology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"37829","DOI":"10.1038\/srep37829","article-title":"Sphingomyelin Generated by Sphingomyelin Synthase 1 Is Involved in Attachment and Infection with Japanese Encephalitis Virus","volume":"6","author":"Taniguchi","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Lo, Y.L., Liou, G.G., Lyu, J.H., Hsiao, M., Hsu, T.L., and Wong, C.H. (2016). Dengue Virus Infection Is through a Cooperative Interaction between a Mannose Receptor and CLEC5A on Macrophage as a Multivalent Hetero-Complex. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0166474"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"24208","DOI":"10.1074\/jbc.M111.226142","article-title":"Structural Flexibility of the Macrophage Dengue Virus Receptor CLEC5A: IMPLICATIONS FOR LIGAND BINDING AND SIGNALING","volume":"286","author":"Watson","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.virol.2013.08.009","article-title":"The Interaction between Claudin-1 and Dengue Viral PrM\/M Protein for Its Entry","volume":"446","author":"Che","year":"2013","journal-title":"Virology"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Xu, Z., Waeckerlin, R., Urbanowski, M.D., van Marle, G., and Hobman, T.C. (2012). West Nile Virus Infection Causes Endocytosis of a Specific Subset of Tight Junction Membrane Proteins. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0037886"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s00705-010-0728-7","article-title":"Dengue-2-Virus-Interacting Polypeptides Involved in Mosquito Cell Infection","volume":"155","author":"Paingankar","year":"2010","journal-title":"Arch. Virol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1128\/JVI.79.8.4557-4567.2005","article-title":"Heat Shock Protein 90 and Heat Shock Protein 70 Are Components of Dengue Virus Receptor Complex in Human Cells","volume":"79","author":"Medina","year":"2005","journal-title":"J. Virol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.cell.2015.10.046","article-title":"Defining Hsp70 Subnetworks in Dengue Virus Replication Reveals Key Vulnerability in Flavivirus Infection","volume":"163","author":"Taguwa","year":"2015","journal-title":"Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.virol.2008.10.025","article-title":"Heat Shock Protein 70 on Neuro2a Cells Is a Putative Receptor for Japanese Encephalitis Virus","volume":"385","author":"Das","year":"2009","journal-title":"Virology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1099\/vir.0.034637-0","article-title":"Association of Heat-Shock Protein 70 with Lipid Rafts Is Required for Japanese Encephalitis Virus Infection in Huh7 Cells","volume":"93","author":"Zhu","year":"2012","journal-title":"J. General. Virol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4269\/ajtmh.2007.77.283","article-title":"Evidence That the 45-KD Glycoprotein, Part of a Putative Dengue Virus Receptor Complex in the Mosquito Cell Line C6\/36, Is a Heat-Shock\u2013Related Protein","volume":"77","author":"Mosso","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1099\/vir.0.033993-0","article-title":"Identification of Heat-Shock Protein 90 Beta in Japanese Encephalitis Virus-Induced Secretion Proteins","volume":"92","author":"Hung","year":"2011","journal-title":"J. General. Virol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jviromet.2008.05.001","article-title":"Identification of Dengue Virus Binding Proteins Using Affinity Chromatography","volume":"151","author":"Upanan","year":"2008","journal-title":"J. Virol. Methods"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e02274-16","DOI":"10.1128\/JVI.02274-16","article-title":"GRP78 Is an Important Host Factor for Japanese Encephalitis Virus Entry and Replication in Mammalian Cells","volume":"91","author":"Nain","year":"2017","journal-title":"J. Virol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1743-422X-8-128","article-title":"Japanese Encephalitis Virus Co-Opts the ER-Stress Response Protein GRP78 for Viral Infectivity","volume":"8","author":"Wu","year":"2011","journal-title":"Virol. J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.virusres.2011.06.001","article-title":"Japanese Encephalitis Virus Interacts with Vimentin to Facilitate Its Entry into Porcine Kidney Cell Line","volume":"160","author":"Das","year":"2011","journal-title":"Virus Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1462-5822.2011.01624.x","article-title":"Vimentin Binding Is Critical for Infection by the Virulent Strain of Japanese Encephalitis Virus","volume":"13","author":"Liang","year":"2011","journal-title":"Cell Microbiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jmv.23248","article-title":"Characterization of Putative Japanese Encephalitis Virus Receptor Molecules on Microglial Cells","volume":"84","author":"Thongtan","year":"2012","journal-title":"J. Med. Virol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"12647","DOI":"10.1128\/JVI.78.22.12647-12656.2004","article-title":"Serotype-Specific Entry of Dengue Virus into Liver Cells: Identification of the 37-Kilodalton\/67-Kilodalton High-Affinity Laminin Receptor as a Dengue Virus Serotype 1 Receptor","volume":"78","author":"Thepparit","year":"2004","journal-title":"J. Virol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Shen, T.J., Hanh, V.T., Nguyen, T.Q., Jhan, M.K., Ho, M.R., and Lin, C.F. (2021). Repurposing the Antiemetic Metoclopramide as an Antiviral Against Dengue Virus Infection in Neuronal Cells. Front. Cell Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.606743"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Simanjuntak, Y., Liang, J.J., Lee, Y.L., and Lin, Y.L. (2017). Japanese Encephalitis Virus Exploits Dopamine D2 Receptor-Phospholipase C to Target Dopaminergic Human Neuronal Cells. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.00651"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1128\/JVI.00365-14","article-title":"Inhibition of Dengue Virus Replication by a Class of Small-Molecule Compounds That Antagonize Dopamine Receptor D4 and Downstream Mitogen-Activated Protein Kinase Signaling","volume":"88","author":"Smith","year":"2014","journal-title":"J. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/jmv.20786","article-title":"Dengue Virus Entry into Liver (HepG2) Cells Is Independent of Hsp90 and Hsp70","volume":"79","author":"Thepparit","year":"2007","journal-title":"J. Med. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/22221751.2018.1557988","article-title":"Heat Shock Protein 70 (Hsp70) Mediates Zika Virus Entry, Replication, and Egress from Host Cells","volume":"8","author":"Pujhari","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.4049\/jimmunol.0802806","article-title":"NKp44 Receptor Mediates Interaction of the Envelope Glycoproteins from the West Nile and Dengue Viruses with NK Cells","volume":"183","author":"Hershkovitz","year":"2009","journal-title":"J. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1128\/JVI.01849-15","article-title":"The Phosphatidylserine and Phosphatidylethanolamine Receptor CD300a Binds Dengue Virus and Enhances Infection","volume":"90","author":"Carnec","year":"2016","journal-title":"J. Virol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/22221751.2019.1590130","article-title":"Cell Surface A2,3-Linked Sialic Acid Facilitates Zika Virus Internalization","volume":"8","author":"Tan","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Sharma, A., Vasanthapuram, R., M Venkataswamy, M., and Desai, A. (2020). Prohibitin 1\/2 Mediates Dengue-3 Entry into Human Neuroblastoma (SH-SY5Y) and Microglia (CHME-3) Cells. J. Biomed. Sci., 27.","DOI":"10.1186\/s12929-020-00639-w"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"11784","DOI":"10.1038\/s41598-018-30054-z","article-title":"PLVAP and GKN3 Are Two Critical Host Cell Receptors Which Facilitate Japanese Encephalitis Virus Entry Into Neurons","volume":"8","author":"Mukherjee","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/v6010069","article-title":"Flavivirus Entry Receptors: An Update","volume":"6","author":"Meertens","year":"2013","journal-title":"Viruses"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1038\/s41467-020-17638-y","article-title":"Chemical Proteomics Tracks Virus Entry and Uncovers NCAM1 as Zika Virus Receptor","volume":"11","author":"Srivastava","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"848","DOI":"10.4269\/ajtmh.2001.65.848","article-title":"Prospective Case-Control Study of Encephalopathy in Children with Dengue Hemorrhagic Fever","volume":"65","author":"Cam","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Estofolete, C.F., Milhim, B.H.G.A., Zini, N., Scamardi, S.N., Selvante, J.D.A., Vasilakis, N., and Nogueira, M.L. (2020). Flavivirus Infection Associated with Cerebrovascular Events. Viruses, 12.","DOI":"10.3390\/v12060671"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Krauer, F., Riesen, M., Reveiz, L., Oladapo, O.T., Mart\u00ednez-Vega, R., Porgo, T.V., Haefliger, A., Broutet, N.J., and Low, N. (2017). Zika Virus Infection as a Cause of Congenital Brain Abnormalities and Guillain-Barr\u00e9 Syndrome: Systematic Review. PLoS Med., 14.","DOI":"10.1371\/journal.pmed.1002203"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"20720","DOI":"10.2807\/1560-7917.ES2014.19.9.20720","article-title":"Zika Virus Infection Complicated by Guillain-Barre Syndrome--Case Report, French Polynesia, December 2013","volume":"19","author":"Oehler","year":"2014","journal-title":"Euro Surveill"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1128\/JVI.78.9.4617-4627.2004","article-title":"Hepatitis C Virus Quasispecies Variability Modulates Nonstructural Protein 5A Transcriptional Activation, Pointing to Cellular Compartmentalization of Virus-Host Interactions","volume":"78","author":"Pellerin","year":"2004","journal-title":"J. Virol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Caldwell, H.S., Pata, J.D., and Ciota, A.T. (2022). The Role of the Flavivirus Replicase in Viral Diversity and Adaptation. Viruses, 14.","DOI":"10.3390\/v14051076"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nrd2424","article-title":"The Design of Drugs for HIV and HCV","volume":"6","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.4254\/wjh.v7.i28.2829","article-title":"Update on Hepatitis C: Direct-Acting Antivirals","volume":"7","author":"Seifert","year":"2015","journal-title":"World J. Hepatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrmicro1067","article-title":"A Structural Perspective of the Flavivirus Life Cycle","volume":"3","author":"Mukhopadhyay","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Gomes da Silva, P., Seixas dos Reis, J.A., Nogueira Rodrigues, M., da Silva Ardaya, Q., and Mesquita, J.R. (2023). Serological Cross-Reactivity in Zoonotic Flaviviral Infections of Medical Importance. Antibodies, 12.","DOI":"10.3390\/antib12010018"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/v3020160","article-title":"Flavivirus Cell Entry and Membrane Fusion","volume":"3","author":"Smit","year":"2011","journal-title":"Viruses"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"van der Schaar, H.M., Rust, M.J., Chen, C., van der Ende-Metselaar, H., Wilschut, J., Zhuang, X., and Smit, J.M. (2008). Dissecting the Cell Entry Pathway of Dengue Virus by Single-Particle Tracking in Living Cells. PLoS Pathog., 4.","DOI":"10.1371\/journal.ppat.1000244"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2005.11.042","article-title":"Cryo-EM Reconstruction of Dengue Virus in Complex with the Carbohydrate Recognition Domain of DC-SIGN","volume":"124","author":"Pokidysheva","year":"2006","journal-title":"Cell"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1128\/jvi.69.9.5816-5820.1995","article-title":"Synthesis and Secretion of Recombinant Tick-Borne Encephalitis Virus Protein E in Soluble and Particulate Form","volume":"69","author":"Allison","year":"1995","journal-title":"J. Virol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0065-3527(03)59002-9","article-title":"Molecular Biology of Flaviviruses","volume":"59","author":"Lindenbach","year":"2003","journal-title":"Adv. Virus Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev.micro.56.012302.160654","article-title":"The Molecular Biology of West Nile Virus: A New Invader of the Western Hemisphere","volume":"56","author":"Brinton","year":"2002","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_86","unstructured":"Knipe, D.M., and Howley, P.M. (2001). Fields Virology, Lippincott Williams, Wilkins."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"12549","DOI":"10.1128\/JVI.01440-10","article-title":"Peptide Inhibitors of Flavivirus Entry Derived from the E Protein Stem","volume":"84","author":"Schmidt","year":"2010","journal-title":"J. Virol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"15672","DOI":"10.1038\/ncomms15672","article-title":"A Peptide-Based Viral Inactivator Inhibits Zika Virus Infection in Pregnant Mice and Fetuses","volume":"8","author":"Yu","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Qian, X., and Qi, Z. (2022). Mosquito-Borne Flaviviruses and Current Therapeutic Advances. Viruses, 14.","DOI":"10.3390\/v14061226"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.bbamem.2014.04.015","article-title":"Peptide Entry Inhibitors of Enveloped Viruses: The Importance of Interfacial Hydrophobicity","volume":"1838","author":"Badani","year":"2014","journal-title":"Biochim. Biophys. Acta (BBA)-Biomembr."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1743-422X-2-49","article-title":"Peptide Inhibitors of Dengue Virus and West Nile Virus Infectivity","volume":"2","author":"Hrobowski","year":"2005","journal-title":"Virol. J."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.antiviral.2017.02.009","article-title":"Antiviral Activity of Peptide Inhibitors Derived from the Protein E Stem against Japanese Encephalitis and Zika Viruses","volume":"141","author":"Chen","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"719","DOI":"10.7150\/ijms.5037","article-title":"Inhibition of Dengue Virus Entry into Target Cells Using Synthetic Antiviral Peptides","volume":"10","author":"Alhoot","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10867-018-9515-6","article-title":"Dynamics and Binding Interactions of Peptide Inhibitors of Dengue Virus Entry","volume":"45","author":"Isa","year":"2019","journal-title":"J. Biol. Phys."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/cbdd.12309","article-title":"Peptide Inhibitors against Dengue Virus Infection","volume":"84","author":"Panya","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/acsinfecdis.8b00322","article-title":"Small Molecules Targeting the Flavivirus E Protein with Broad-Spectrum Activity and Antiviral Efficacy in Vivo","volume":"5","author":"Li","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.cell.2015.06.057","article-title":"Structure-Guided Design of an Anti-Dengue Antibody Directed to a Non-Immunodominant Epitope","volume":"162","author":"Robinson","year":"2015","journal-title":"Cell"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.aaa8651","article-title":"Cryo-EM Structure of an Antibody That Neutralizes Dengue Virus Type 2 by Locking E Protein Dimers","volume":"349","author":"Fibriansah","year":"2015","journal-title":"Science"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Komarasamy, T.V., Adnan, N.A.A., James, W., and Balasubramaniam, V.R.M.T. (2022). Finding a Chink in the Armor: Update, Limitations, and Challenges toward Successful Antivirals against Flaviviruses. PLoS Negl. Trop. Dis., 16.","DOI":"10.1371\/journal.pntd.0010291"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.4269\/ajtmh.20-1578","article-title":"Results of a Double-Blind, Randomized, Placebo-Controlled Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Anti-Zika Virus Immunoglobulin","volume":"105","author":"White","year":"2021","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1128\/AAC.01178-09","article-title":"Safety and Pharmacokinetics of Single Intravenous Dose of MGAWN1, a Novel Monoclonal Antibody to West Nile Virus","volume":"54","author":"Beigel","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12985-017-0895-1","article-title":"Geraniin Extracted from the Rind of Nephelium Lappaceum Binds to Dengue Virus Type-2 Envelope Protein and Inhibits Early Stage of Virus Replication","volume":"14","author":"Palanisamy","year":"2017","journal-title":"Virol. J."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12985-019-1127-7","article-title":"Efficacy of Geraniin on Dengue Virus Type-2 Infected BALB\/c Mice","volume":"16","author":"Palanisamy","year":"2019","journal-title":"Virol. J."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00705-010-0702-4","article-title":"Identification of Palmatine as an Inhibitor of West Nile Virus","volume":"155","author":"Jia","year":"2010","journal-title":"Arch. Virol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/infdis\/jiu377","article-title":"Repurposing of Prochlorperazine for Use Against Dengue Virus Infection","volume":"211","author":"Simanjuntak","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"31365","DOI":"10.1073\/pnas.2005463117","article-title":"Therapeutic Candidates for the Zika Virus Identified by a High-Throughput Screen for Zika Protease Inhibitors","volume":"117","author":"Abrams","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.chom.2016.07.004","article-title":"A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection","volume":"20","author":"Barrows","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.celrep.2016.12.068","article-title":"Screening Bioactives Reveals Nanchangmycin as a Broad Spectrum Antiviral Active against Zika Virus","volume":"18","author":"Rausch","year":"2017","journal-title":"Cell Rep."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.antiviral.2018.05.001","article-title":"Feasibility and Biological Rationale of Repurposing Sunitinib and Erlotinib for Dengue Treatment","volume":"155","author":"Pu","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.immuni.2017.02.012","article-title":"25-Hydroxycholesterol Protects Host against Zika Virus Infection and Its Associated Microcephaly in a Mouse Model","volume":"46","author":"Li","year":"2017","journal-title":"Immunity"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of Chloroquine on Viral Infections: An Old Drug against Today\u2019s Diseases","volume":"3","author":"Savarino","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and Chloroquine Effectively Inhibit the Recently Emerged Novel Coronavirus (2019-NCoV) In Vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Tricou, V., Minh, N.N., Van, T.P., Lee, S.J., Farrar, J., Wills, B., Tran, H.T., and Simmons, C.P. (2010). A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese Adults. PLoS Negl. Trop. Dis., 4.","DOI":"10.1371\/journal.pntd.0000785"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/cr.2017.88","article-title":"Existing Drugs as Broad-Spectrum and Potent Inhibitors for Zika Virus by Targeting NS2B-NS3 Interaction","volume":"27","author":"Li","year":"2017","journal-title":"Cell Res."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Lok, S.-M., Costin, J.M., Hrobowski, Y.M., Hoffmann, A.R., Rowe, D.K., Kukkaro, P., Holdaway, H., Chipman, P., Fontaine, K.A., and Holbrook, M.R. (2012). Release of Dengue Virus Genome Induced by a Peptide Inhibitor. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0050995"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1016\/S1473-3099(22)00311-5","article-title":"Monoclonal Antibody Therapies against SARS-CoV-2","volume":"22","author":"Focosi","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41423-018-0043-x","article-title":"Advances in the Research and Development of Therapeutic Antibodies against the Zika Virus","volume":"16","author":"Jiang","year":"2019","journal-title":"Cell Mol. Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Mancini, N. (2022). Monoclonal Antibodies and Flaviviruses: A Possible Option?. mBio, 13.","DOI":"10.1128\/mbio.00824-22"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.molimm.2022.11.010","article-title":"Antibody-Dependent Enhancement (ADE) and the Role of Complement System in Disease Pathogenesis","volume":"152","author":"Thomas","year":"2022","journal-title":"Mol. Immunol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.bbrc.2019.08.120","article-title":"Palmatine Inhibits Zika Virus Infection by Disrupting Virus Binding, Entry, and Stability","volume":"518","author":"Ho","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Mustaf\u00e1, Y.M., Meuren, L.M., Coelho, S.V.A., and De Arruda, L.B. (2019). Pathways Exploited by Flaviviruses to Counteract the Blood-Brain Barrier and Invade the Central Nervous System. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.00525"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/bies.201400182","article-title":"Structure-Guided Insights on the Role of NS1 in Flavivirus Infection","volume":"37","author":"Akey","year":"2015","journal-title":"BioEssays"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.coviro.2014.09.020","article-title":"Coupling of Replication and Assembly in Flaviviruses","volume":"9","author":"Sirohi","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.chom.2009.03.007","article-title":"Composition and Three-Dimensional Architecture of the Dengue Virus Replication and Assembly Sites","volume":"5","author":"Welsch","year":"2009","journal-title":"Cell Host Microbe"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"12933","DOI":"10.1038\/s41598-020-69515-9","article-title":"Peptides Targeting Dengue Viral Nonstructural Protein 1 Inhibit Dengue Virus Production","volume":"10","author":"Songprakhon","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Sun, E.-C., Ma, J.-N., Liu, N.-H., Yang, T., Zhao, J., Geng, H.-W., Wang, L.-F., Qin, Y.-L., Bu, Z.-G., and Yang, Y.-H. (2011). Identification of Two Linear B-Cell Epitopes from West Nile Virus NS1 by Screening a Phage-Displayed Random Peptide Library. BMC Microbiol., 11.","DOI":"10.1186\/1471-2180-11-160"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1109\/TCBB.2019.2911081","article-title":"Screening Pipeline for Flavivirus Based Inhibitors for Zika Virus NS1","volume":"17","author":"Raza","year":"2020","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinform."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1038\/s41467-018-07008-0","article-title":"Human Antibodies Targeting Zika Virus NS1 Provide Protection against Disease in a Mouse Model","volume":"9","author":"Bailey","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1126\/science.abc0476","article-title":"Structural Basis for Antibody Inhibition of Flavivirus NS1\u2013Triggered Endothelial Dysfunction","volume":"371","author":"Biering","year":"2021","journal-title":"Science"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1128\/JVI.74.1.564-572.2000","article-title":"\u03b1-Glucosidase Inhibitors Reduce Dengue Virus Production by Affecting the Initial Steps of Virion Morphogenesis in the Endoplasmic Reticulum","volume":"74","author":"Courageot","year":"2000","journal-title":"J. Virol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1128\/JVI.76.8.3596-3604.2002","article-title":"Antiviral Effects of an Iminosugar Derivative on Flavivirus Infections","volume":"76","author":"Wu","year":"2002","journal-title":"J. Virol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1073\/pnas.1322036111","article-title":"Structural Basis of Flavivirus NS1 Assembly and Antibody Recognition","volume":"111","author":"Edeling","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1473-3099(14)70770-4","article-title":"Stumbles on the Path to Dengue Control","volume":"14","author":"Halstead","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.virol.2014.01.025","article-title":"Effective Inhibition of Japanese Encephalitis Virus Replication by ShRNAs Targeting Various Viral Genes in Vitro and in Vivo","volume":"454\u2013455","author":"Shen","year":"2014","journal-title":"Virology"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Wu, Z., Xue, Y., Wang, B., Du, J., and Jin, Q. (2011). Broad-Spectrum Antiviral Activity of RNA Interference against Four Genotypes of Japanese Encephalitis Virus Based on Single MicroRNA Polycistrons. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0026304"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"104668","DOI":"10.1016\/j.antiviral.2019.104668","article-title":"In Silico Drug Repurposing for the Identification of Potential Candidate Molecules against Arboviruses Infection","volume":"173","author":"Espinosa","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.antiviral.2017.07.007","article-title":"Structure-Based Discovery of Clinically Approved Drugs as Zika Virus NS2B-NS3 Protease Inhibitors That Potently Inhibit Zika Virus Infection In Vitro and In Vivo","volume":"145","author":"Yuan","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1021\/acsinfecdis.0c00217","article-title":"JMX0207, a Niclosamide Derivative with Improved Pharmacokinetics, Suppresses Zika Virus Infection Both In Vitro and In Vivo","volume":"6","author":"Li","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"85938","DOI":"10.1039\/C5RA14469H","article-title":"Reaching beyond HIV\/HCV: Nelfinavir as a Potential Starting Point for Broad-Spectrum Protease Inhibitors against Dengue and Chikungunya Virus","volume":"5","author":"Bhakat","year":"2015","journal-title":"RSC Adv."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ejmech.2019.07.007","article-title":"Cell-Active Carbazole Derivatives as Inhibitors of the Zika Virus Protease","volume":"180","author":"Rassias","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejmech.2015.12.030","article-title":"Discovery of Antiviral Molecules for Dengue: In Silico Search and Biological Evaluation","volume":"110","author":"Sztajer","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Brecher, M., Li, Z., Liu, B., Zhang, J., Koetzner, C.A., Alifarag, A., Jones, S.A., Lin, Q., Kramer, L.D., and Li, H. (2017). A Conformational Switch High-Throughput Screening Assay and Allosteric Inhibition of the Flavivirus NS2B-NS3 Protease. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006411"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"514313","DOI":"10.3389\/fphar.2020.514313","article-title":"Identification of Theaflavin-3,3\u2032-Digallate as a Novel Zika Virus Protease Inhibitor","volume":"11","author":"Cui","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1110\/ps.072753207","article-title":"Structural Evidence for Regulation and Specificity of Flaviviral Proteases and Evolution of the Flaviviridae Fold","volume":"16","author":"Aleshin","year":"2007","journal-title":"Protein Sci."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12985-015-0248-x","article-title":"A Small Molecule Inhibitor of Dengue Virus Type 2 Protease Inhibits the Replication of All Four Dengue Virus Serotypes in Cell Culture","volume":"12","author":"Raut","year":"2015","journal-title":"Virol. J."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"18132","DOI":"10.1021\/acsomega.8b01002","article-title":"Hydroxychloroquine Inhibits Zika Virus NS2B-NS3 Protease","volume":"3","author":"Kumar","year":"2018","journal-title":"ACS Omega"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/aps.2013.5","article-title":"Application and Interpretation of Current Autophagy Inhibitors and Activators","volume":"34","author":"Yang","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1080\/22221751.2020.1838954","article-title":"Methylene Blue Is a Potent and Broad-Spectrum Inhibitor against Zika Virus In Vitro and In Vivo","volume":"9","author":"Li","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.antiviral.2017.12.018","article-title":"Erythrosin B Is a Potent and Broad-Spectrum Orthosteric Inhibitor of the Flavivirus NS2B-NS3 Protease","volume":"150","author":"Li","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.apsb.2021.10.017","article-title":"In Vitro and in Vivo Characterization of Erythrosin B and Derivatives against Zika Virus","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/jac\/dks147","article-title":"Ivermectin Is a Potent Inhibitor of Flavivirus Replication Specifically Targeting NS3 Helicase Activity: New Prospects for an Old Drug","volume":"67","author":"Mastrangelo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.diagmicrobio.2019.03.012","article-title":"Lack of Efficacy of Ivermectin for Prevention of a Lethal Zika Virus Infection in a Murine System","volume":"95","author":"Ketkar","year":"2019","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"104787","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-Approved Drug Ivermectin Inhibits the Replication of SARS-CoV-2 in Vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.chembiol.2022.10.003","article-title":"Bortezomib Inhibits ZIKV\/DENV by Interfering with Viral Polyprotein Cleavage via the ERAD Pathway","volume":"30","author":"Ci","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Pathak, N., Lai, M.-L., Chen, W.-Y., Hsieh, B.-W., Yu, G.-Y., and Yang, J.-M. (2017). Pharmacophore Anchor Models of Flaviviral NS3 Proteases Lead to Drug Repurposing for DENV Infection. BMC Bioinform., 18.","DOI":"10.1186\/s12859-017-1957-5"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1128\/AAC.02251-12","article-title":"Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase","volume":"57","author":"Byrd","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbrc.2014.09.113","article-title":"Suramin Inhibits Helicase Activity of NS3 Protein of Dengue Virus in a Fluorescence-Based High Throughput Assay Format","volume":"453","author":"Basavannacharya","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.antiviral.2017.04.015","article-title":"Characterization of the Zika Virus Two-Component NS2B-NS3 Protease and Structure-Assisted Identification of Allosteric Small-Molecule Antagonists","volume":"143","author":"Shiryaev","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.antiviral.2018.05.003","article-title":"Identification of Compound-B, a Novel Anti-Dengue Virus Agent Targeting the Non-Structural Protein 4A","volume":"155","author":"Nobori","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1128\/JVI.00996-21","article-title":"The Compound SBI-0090799 Inhibits Zika Virus Infection by Blocking De Novo Formation of the Membranous Replication Compartment","volume":"95","author":"Riva","year":"2021","journal-title":"J. Virol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41586-021-03990-6","article-title":"A Pan-Serotype Dengue Virus Inhibitor Targeting the NS3\u2013NS4B Interaction","volume":"598","author":"Kaptein","year":"2021","journal-title":"Nature"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"105495","DOI":"10.1016\/j.antiviral.2022.105495","article-title":"A pan-serotype antiviral to prevent and treat dengue: A journey from discovery to clinical development driven by public-private partnerships","volume":"210","author":"Goethals","year":"2023","journal-title":"Antiviral Res."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1126\/scitranslmed.abb2181","article-title":"NITD-688, a Pan-Serotype Inhibitor of the Dengue Virus NS4B Protein, Shows Favorable Pharmacokinetics and Efficacy in Preclinical Animal Models","volume":"13","author":"Moquin","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"e01055-17","DOI":"10.1128\/JVI.01055-17","article-title":"Screening of FDA-Approved Drugs for Inhibitors of Japanese Encephalitis Virus Infection","volume":"91","author":"Wang","year":"2017","journal-title":"J. Virol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"7367","DOI":"10.1128\/JVI.00632-13","article-title":"The Small Molecules AZD0530 and Dasatinib Inhibit Dengue Virus RNA Replication via Fyn Kinase","volume":"87","author":"LaCroix","year":"2013","journal-title":"J. Virol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/rmv.1835","article-title":"Flaviviral NS4b, Chameleon and Jack-in-the-box Roles in Viral Replication and Pathogenesis, and a Molecular Target for Antiviral Intervention","volume":"25","author":"Zmurko","year":"2015","journal-title":"Rev. Med. Virol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2017.03.012","article-title":"Antiviral Activity of the Adenosine Analogue BCX4430 against West Nile Virus and Tick-Borne Flaviviruses","volume":"142","author":"Eyer","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.antiviral.2016.11.003","article-title":"Efficacy of the Broad-Spectrum Antiviral Compound BCX4430 against Zika Virus in Cell Culture and in a Mouse Model","volume":"137","author":"Julander","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"105180","DOI":"10.1016\/j.antiviral.2021.105180","article-title":"An Update on the Progress of Galidesivir (BCX4430), a Broad-Spectrum Antiviral","volume":"195","author":"Julander","year":"2021","journal-title":"Antivir. Res."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"e01400-17","DOI":"10.1128\/AAC.01400-17","article-title":"Extinction of West Nile Virus by Favipiravir through Lethal Mutagenesis","volume":"61","author":"Domingo","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1038\/s41467-022-32565-w","article-title":"Antiviral Efficacy of Favipiravir against Zika and SARS-CoV-2 Viruses in Non-Human Primates","volume":"13","author":"Marlin","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1128\/JVI.02841-13","article-title":"Activation of Peripheral Blood Mononuclear Cells by Dengue Virus Infection Depotentiates Balapiravir","volume":"88","author":"Chen","year":"2014","journal-title":"J. Virol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"ofw175","DOI":"10.1093\/ofid\/ofw175","article-title":"Adenosine Analog NITD008 Is a Potent Inhibitor of Zika Virus","volume":"3","author":"Deng","year":"2016","journal-title":"Open Forum Infect. Dis."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Lee, M.F., Wu, Y.S., and Poh, C.L. (2023). Molecular Mechanisms of Antiviral Agents against Dengue Virus. Viruses, 15.","DOI":"10.3390\/v15030705"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"e0098821","DOI":"10.1128\/AAC.00988-21","article-title":"Evaluation of AT-752, a Double Prodrug of a Guanosine Nucleotide Analog with In Vitro and In Vivo Activity against Dengue and Other Flaviviruses","volume":"65","author":"Good","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Lin, K., Good, S.S., Julander, J.G., Weight, A.E., Moussa, A., and Sommadossi, J.P. (2022). AT-752, a Double Prodrug of a Guanosine Nucleotide Analog, Inhibits Yellow Fever Virus in a Hamster Model. PLoS Negl. Trop. Dis., 16.","DOI":"10.1371\/journal.pntd.0009937"},{"key":"ref_177","first-page":"02093-18","article-title":"Viral RNA-Dependent RNA Polymerase Inhibitor 7-Deaza-2\u2032-C-Methyladenosine Prevents Death in a Mouse Model of West Nile Virus Infection","volume":"63","author":"Eyer","year":"2019","journal-title":"Am. Soc. Microbiol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1086\/511310","article-title":"A Dengue Fever Viremia Model in Mice Shows Reduction in Viral Replication and Suppression of the Inflammatory Response after Treatment with Antiviral Drugs","volume":"195","author":"Schul","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"de Freitas, C.S., Higa, L.M., Sacramento, C.Q., Ferreira, A.C., Reis, P.A., Delvecchio, R., Monteiro, F.L., Barbosa-Lima, G., James Westgarth, H., and Vieira, Y.R. (2019). Yellow Fever Virus Is Susceptible to Sofosbuvir Both In Vitro and In Vivo. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007072"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/hmg\/ddx382","article-title":"Zanotto, P.M.; Beltr\u00e3o-Braga, P.C.B.; Nizet, V.; Muotri, A.R. Modeling Neuro-Immune Interactions during Zika Virus Infection","volume":"27","author":"Mesci","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"40920","DOI":"10.1038\/srep40920","article-title":"The Clinically Approved Antiviral Drug Sofosbuvir Inhibits Zika Virus Replication","volume":"7","author":"Sacramento","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"e01130-20","DOI":"10.1128\/JVI.01130-20","article-title":"Two RNA Tunnel Inhibitors Bind in Highly Conserved Sites in Dengue Virus NS5 Polymerase: Structural and Functional Studies","volume":"94","author":"Arora","year":"2020","journal-title":"J. Virol."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Lim, S.P., Noble, C.G., Seh, C.C., Soh, T.S., El Sahili, A., Chan, G.K.Y., Lescar, J., Arora, R., Benson, T., and Nilar, S. (2016). Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005737"},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Stefanik, M., Valdes, J.J., Ezebuo, F.C., Haviernik, J., Uzochukwu, I.C., Fojtikova, M., Salat, J., Eyer, L., and Ruzek, D. (2020). FDA-Approved Drugs Efavirenz, Tipranavir, and Dasabuvir Inhibit Replication of Multiple Flaviviruses in Vero Cells. Microorganisms, 8.","DOI":"10.3390\/microorganisms8040599"},{"key":"ref_185","first-page":"1","article-title":"Novel AR-12 Derivatives, P12-23 and P12-34, Inhibit Flavivirus Replication by Blocking Host de Novo Pyrimidine Biosynthesis","volume":"7","author":"Yang","year":"2018","journal-title":"Emerg. Microbes Infect."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2017.08.007","article-title":"Ribavirin Inhibits Zika Virus (ZIKV) Replication in Vitro and Suppresses Viremia in ZIKV-Infected STAT1-Deficient Mice","volume":"146","author":"Kamiyama","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1042\/BJ20120150","article-title":"Ivermectin Is a Specific Inhibitor of Importin \u03b1\/\u03b2-Mediated Nuclear Import Able to Inhibit Replication of HIV-1 and Dengue Virus","volume":"443","author":"Wagstaff","year":"2012","journal-title":"Biochem. J."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"e586","DOI":"10.1093\/cid\/ciaa1332","article-title":"Ivermectin Accelerates Circulating Nonstructural Protein 1 (NS1) Clearance in Adult Dengue Patients: A Combined Phase 2\/3 Randomized Double-Blinded Placebo Controlled Trial","volume":"72","author":"Suputtamongkol","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.antiviral.2017.06.006","article-title":"Emetine Inhibits Replication of RNA and DNA Viruses without Generating Drug-Resistant Virus Variants","volume":"144","author":"Khandelwal","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.virol.2020.04.009","article-title":"Antiviral Activity of Lycorine against Zika Virus In Vivo and In Vitro","volume":"546","author":"Chen","year":"2020","journal-title":"Virology"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41421-018-0034-1","article-title":"Emetine Inhibits Zika and Ebola Virus Infections through Two Molecular Mechanisms: Inhibiting Viral Replication and Decreasing Viral Entry","volume":"4","author":"Yang","year":"2018","journal-title":"Cell Discov."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.antiviral.2017.12.016","article-title":"Discovery of a Non-Nucleoside RNA Polymerase Inhibitor for Blocking Zika Virus Replication through in Silico Screening","volume":"151","author":"Pattnaik","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.antiviral.2015.04.010","article-title":"The Dengue Virus NS5 Protein as a Target for Drug Discovery","volume":"119","author":"Lim","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.virol.2010.03.011","article-title":"Higher Catalytic Efficiency of N-7-Methylation Is Responsible for Processive N-7 and 2\u2032-O Methyltransferase Activity in Dengue Virus","volume":"402","author":"Chung","year":"2010","journal-title":"Virology"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.antiviral.2014.09.003","article-title":"Crystal Structure of Dengue Virus Methyltransferase without S-Adenosyl-L-Methionine","volume":"111","author":"Noble","year":"2014","journal-title":"Antivir. Res."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1084\/jem.20092545","article-title":"Antagonism of the Complement Component C4 by Flavivirus Nonstructural Protein NS1","volume":"207","author":"Avirutnan","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"424","DOI":"10.4049\/jimmunol.1100750","article-title":"Binding of Flavivirus Nonstructural Protein NS1 to C4b Binding Protein Modulates Complement Activation","volume":"187","author":"Avirutnan","year":"2011","journal-title":"J. Immunol."},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Ci, Y., Liu, Z.-Y., Zhang, N.-N., Niu, Y., Yang, Y., Xu, C., Yang, W., Qin, C.-F., and Shi, L. (2020). Zika NS1-Induced ER Remodeling Is Essential for Viral Replication. J. Cell Biol., 219.","DOI":"10.1083\/jcb.201903062"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12985-016-0590-7","article-title":"Flavivirus NS1: A Multifaceted Enigmatic Viral Protein","volume":"13","author":"Rastogi","year":"2016","journal-title":"Virol. J."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Xu, X., Vaughan, K., Weiskopf, D., Grifoni, A., Diamond, M.S., Sette, A., and Peters, B. (2016). Identifying Candidate Targets of Immune Responses in Zika Virus Based on Homology to Epitopes in Other Flavivirus Species. PLoS Curr., 15.","DOI":"10.1371\/currents.outbreaks.9aa2e1fb61b0f632f58a098773008c4b"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0042-6822(88)90408-4","article-title":"Evidence That the Mature Form of the Flavivirus Nonstructural Protein NS1 Is a Dimer","volume":"162","author":"Winkler","year":"1988","journal-title":"Virology"},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Lebani, K., Jones, M.L., Watterson, D., Ranzoni, A., Traves, R.J., Young, P.R., and Mahler, S.M. (2017). Isolation of Serotype-Specific Antibodies against Dengue Virus Non-Structural Protein 1 Using Phage Display and Application in a Multiplexed Serotyping Assay. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0180669"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.tibs.2020.12.007","article-title":"Molecular Determinants of Flavivirus Virion Assembly","volume":"46","author":"Barnard","year":"2021","journal-title":"Trends Biochem. Sci."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2009.11.009","article-title":"Structure and Functionality in Flavivirus NS-Proteins: Perspectives for Drug Design","volume":"87","author":"Bollati","year":"2010","journal-title":"Antivir. Res."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nsmb1073","article-title":"Structural Basis for the Activation of Flaviviral NS3 Proteases from Dengue and West Nile Virus","volume":"13","author":"Erbel","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.antiviral.2017.04.016","article-title":"Suramin Inhibits Zika Virus Replication by Interfering with Virus Attachment and Release of Infectious Particles","volume":"143","author":"Albulescu","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Klaitong, P., and Smith, D.R. (2021). Roles of Non-Structural Protein 4A in Flavivirus Infection. Viruses, 13.","DOI":"10.3390\/v13102077"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"105423","DOI":"10.1016\/j.antiviral.2022.105423","article-title":"Flavivirus NS4B Protein: Structure, Function, and Antiviral Discovery","volume":"207","author":"Wang","year":"2022","journal-title":"Antivir. Res."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"7170","DOI":"10.1128\/JVI.00867-15","article-title":"A Combined Genetic-Proteomic Approach Identifies Residues within Dengue Virus NS4B Critical for Interaction with NS3 and Viral Replication","volume":"89","author":"Fischl","year":"2015","journal-title":"J. Virol."},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Li, Q., and Kang, C. (2022). Dengue Virus NS4B Protein as a Target for Developing Antivirals. Front. Cell Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.959727"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41586-023-05790-6","article-title":"Blocking NS3\u2013NS4B Interaction Inhibits Dengue Virus in Non-Human Primates","volume":"615","author":"Goethals","year":"2023","journal-title":"Nature"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/cid\/ciad284","article-title":"Safety, Tolerability, and Pharmacokinetics of JNJ-1802, a Pan-Serotype Dengue Direct Antiviral Small Molecule, in a Phase 1, Double-Blind, Randomized, Dose-Escalation Study in Healthy Volunteers","volume":"77","author":"Ackaert","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1128\/JVI.02704-06","article-title":"Structure and Function of Flavivirus NS5 Methyltransferase","volume":"81","author":"Zhou","year":"2007","journal-title":"J. Virol."},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"\u00c1lvarez, D.M., Castillo, E., Duarte, L.F., Arriagada, J., Corrales, N., Far\u00edas, M.A., Henr\u00edquez, A., Agurto-Mu\u00f1oz, C., and Gonz\u00e1lez, P.A. (2020). Current Antivirals and Novel Botanical Molecules Interfering with Herpes Simplex Virus Infection. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.00139"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1038\/ctg.2017.51","article-title":"Seven-Year Treatment Outcome of Entecavir in a Real-World Cohort: Effects on Clinical Parameters, HBsAg and HBcrAg Levels","volume":"8","author":"Lam","year":"2017","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1756283X13515825","article-title":"Sofosbuvir, a NS5B Polymerase Inhibitor in the Treatment of Hepatitis C: A Review of Its Clinical Potential","volume":"7","author":"Stedman","year":"2013","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Abdullah Al Awadh, A. (2022). Nucleotide and Nucleoside-Based Drugs: Past, Present, and Future. Saudi J. Biol. Sci., 29.","DOI":"10.1016\/j.sjbs.2022.103481"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"204020661876129","DOI":"10.1177\/2040206618761299","article-title":"Nucleoside Analogs as a Rich Source of Antiviral Agents Active against Arthropod-Borne Flaviviruses","volume":"26","author":"Eyer","year":"2018","journal-title":"Antivir. Chem. Chemother."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s10593-021-02912-8","article-title":"Antiviral Nucleoside Analogs","volume":"57","author":"Kataev","year":"2021","journal-title":"Chem Heterocycl Compd."},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Geraghty, R.J., Aliota, M.T., and Bonnac, L.F. (2021). Broad-Spectrum Antiviral Strategies and Nucleoside Analogues. Viruses, 13.","DOI":"10.3390\/v13040667"},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Guedj, J., Piorkowski, G., Jacquot, F., Madelain, V., Nguyen, T.H.T., Rodallec, A., Gunther, S., Carbonnelle, C., Mentr\u00e9, F., and Raoul, H. (2018). Antiviral Efficacy of Favipiravir against Ebola Virus: A Translational Study in Cynomolgus Macaques. PLoS Med., 15.","DOI":"10.1371\/journal.pmed.1002535"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"101703","DOI":"10.1016\/j.eclinm.2022.101703","article-title":"Favipiravir in Early Symptomatic COVID-19, a Randomised Placebo-Controlled Trial","volume":"54","author":"McMahon","year":"2022","journal-title":"EClinicalMedicine"},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Franco, E.J., Cella, E., Tao, X., Hanrahan, K.C., Azarian, T., and Brown, A.N. (2023). Favipiravir Suppresses Zika Virus (ZIKV) through Activity as a Mutagen. Microorganisms, 11.","DOI":"10.3390\/microorganisms11051342"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/infdis\/jis470","article-title":"A Randomized, Double-Blind Placebo Controlled Trial of Balapiravir, a Polymerase Inhibitor, in Adult Dengue Patients","volume":"207","author":"Nguyen","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1073\/pnas.0907010106","article-title":"An Adenosine Nucleoside Inhibitor of Dengue Virus","volume":"106","author":"Yin","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Arnold, J.J., Sharma, S.D., Feng, J.Y., Ray, A.S., Smidansky, E.D., Kireeva, M.L., Cho, A., Perry, J., Vela, J.E., and Park, Y. (2012). Sensitivity of Mitochondrial Transcription and Resistance of RNA Polymerase II Dependent Nuclear Transcription to Antiviral Ribonucleosides. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1003030"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.antiviral.2013.09.013","article-title":"Ten Years of Dengue Drug Discovery: Progress and Prospects","volume":"100","author":"Lim","year":"2013","journal-title":"Antivir. Res."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1126\/science.1259210","article-title":"Structural Basis for RNA Replication by the Hepatitis C Virus Polymerase","volume":"347","author":"Appleby","year":"2015","journal-title":"Science"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"104708","DOI":"10.1016\/j.antiviral.2020.104708","article-title":"Evaluation of Sofosbuvir Activity and Resistance Profile against West Nile Virus in Vitro","volume":"175","author":"Dragoni","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1007\/s12035-021-02508-5","article-title":"Dolutegravir Inhibition of Matrix Metalloproteinases Affects Mouse Neurodevelopment","volume":"58","author":"Bade","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"ref_231","first-page":"262","article-title":"Immunovirological Outcome and HIV-1 DNA Decay in a Small Cohort of HIV-1-Infected Patients Deintensificated from Abacavir\/Lamivudine\/Dolutegravir to Lamivudine plus Dolutegravir","volume":"41","author":"Lanzafame","year":"2018","journal-title":"New Microbiol."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/jac\/dkx109","article-title":"Dolutegravir Monotherapy in HIV-Infected Naive Patients with an HIV-RNA Load &lt;100\u2009000 Copies\/ML: A Medium-Term Follow-Up","volume":"72","author":"Lanzafame","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"ofac107","DOI":"10.1093\/ofid\/ofac107","article-title":"Dolutegravir Monotherapy as Maintenance Strategy: A Meta-Analysis of Individual Participant Data From Randomized Controlled Trials","volume":"9","author":"Fournier","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/bs.aivir.2020.08.003","article-title":"Structure-Guided Paradigm Shifts in Flavivirus Assembly and Maturation Mechanisms","volume":"108","author":"Nicholls","year":"2020","journal-title":"Adv. Virus Res."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.antiviral.2011.10.002","article-title":"Celgosivir Treatment Misfolds Dengue Virus NS1 Protein, Induces Cellular pro-Survival Genes and Protects against Lethal Challenge Mouse Model","volume":"92","author":"Rathore","year":"2011","journal-title":"Antivir. Res."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"8698","DOI":"10.1128\/JVI.79.14.8698-8706.2005","article-title":"Castanospermine, a Potent Inhibitor of Dengue Virus Infection In Vitro and In Vivo","volume":"79","author":"Whitby","year":"2005","journal-title":"J. Virol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.antiviral.2015.12.008","article-title":"Optimizing Celgosivir Therapy in Mouse Models of Dengue Virus Infection of Serotypes 1 and 2: The Search for a Window for Potential Therapeutic Efficacy","volume":"127","author":"Watanabe","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S1473-3099(14)70730-3","article-title":"Efficacy and Safety of Celgosivir in Patients with Dengue Fever (CELADEN): A Phase 1b, Randomised, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial","volume":"14","author":"Low","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref_239","doi-asserted-by":"crossref","unstructured":"Sung, C., Wei, Y., Watanabe, S., Lee, H.S., Khoo, Y.M., Fan, L., Rathore, A.P.S., Chan, K.W.K., Choy, M.M., and Kamaraj, U.S. (2016). Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0004851"},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"Callahanid, M., Trestonid, A.M., Lin, G., Smith, M., Kaufman, B., Khaliq, M., Dewald, L.E., Spurgers, K., Warfield, K.L., and Lowe, P. (2022). Randomized Single Oral Dose Phase 1 Study of Safety, Tolerability, and Pharmacokinetics of Iminosugar UV-4 Hydrochloride (UV-4B) in Healthy Subjects. PLoS Negl. Trop. Dis., 16.","DOI":"10.1371\/journal.pntd.0010636"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.antiviral.2010.11.002","article-title":"Combination of Alpha-Glucosidase Inhibitor and Ribavirin for the Treatment of Dengue Virus Infection In Vitro and In Vivo","volume":"89","author":"Chang","year":"2011","journal-title":"Antivir. Res."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"104881","DOI":"10.1016\/j.antiviral.2020.104881","article-title":"Iminosugars: A Host-Targeted Approach to Combat Flaviviridae Infections","volume":"184","author":"Starr","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.3390\/v7052404","article-title":"A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue)","volume":"7","author":"Warfield","year":"2015","journal-title":"Viruses"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/22221751.2019.1604084","article-title":"Targeting Host Metabolism by Inhibition of Acetyl-Coenzyme A Carboxylase Reduces Flavivirus Infection in Mouse Models","volume":"8","author":"Esler","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1128\/AAC.01578-15","article-title":"Modification of the Host Cell Lipid Metabolism Induced by Hypolipidemic Drugs Targeting the Acetyl Coenzyme A Carboxylase Impairs West Nile Virus Replication","volume":"60","author":"Casas","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_246","doi-asserted-by":"crossref","unstructured":"Anwar, A., Hosoya, T., Leong, K.M., Onogi, H., Okuno, Y., Hiramatsu, T., Koyama, H., Suzuki, M., Hagiwara, M., and Garcia-Blanco, M.A. (2011). The Kinase Inhibitor SFV785 Dislocates Dengue Virus Envelope Protein from the Replication Complex and Blocks Virus Assembly. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023246"},{"key":"ref_247","doi-asserted-by":"crossref","unstructured":"Bl\u00e1zquez, A.-B., and Saiz, J.-C. (2020). Potential for Protein Kinase Pharmacological Regulation in Flaviviridae Infections. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249524"},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Martinez-Gutierrez, M., Correa-Londo\u00f1o, L.A., Castellanos, J.E., Gallego-G\u00f3mez, J.C., and Osorio, J.E. (2014). Lovastatin Delays Infection and Increases Survival Rates in AG129 Mice Infected with Dengue Virus Serotype 2. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0087412"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.virol.2009.03.025","article-title":"Cholesterol Biosynthesis Modulation Regulates Dengue Viral Replication","volume":"389","author":"Rothwell","year":"2009","journal-title":"Virology"},{"key":"ref_250","first-page":"468","article-title":"Lovastatin for the Treatment of Adult Patients with Dengue: A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"62","author":"Whitehorn","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_251","doi-asserted-by":"crossref","unstructured":"Osuna-Ramos, J.F., Farfan-Morales, C.N., Cordero-Rivera, C.D., De Jes\u00fas-Gonz\u00e1lez, L.A., Reyes-Ruiz, J.M., Hurtado-Monz\u00f3n, A.M., Palacios-R\u00e1palo, S.N., Jim\u00e9nez-Camacho, R., Meraz-R\u00edos, M.A., and Del \u00c1ngel, R.M. (2023). Cholesterol-Lowering Drugs as Potential Antivirals: A Repurposing Approach against Flavivirus Infections. Viruses, 15.","DOI":"10.3390\/v15071465"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.antiviral.2018.04.019","article-title":"Characterization and Structure-Activity Relationship Analysis of a Class of Antiviral Compounds That Directly Bind Dengue Virus Capsid Protein and Are Incorporated into Virions","volume":"155","author":"Smith","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/AAC.01429-12","article-title":"A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein","volume":"57","author":"Byrd","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"17992","DOI":"10.1073\/pnas.2003056117","article-title":"A Cocrystal Structure of Dengue Capsid Protein in Complex of Inhibitor","volume":"117","author":"Xia","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_255","doi-asserted-by":"crossref","unstructured":"Sotcheff, S., and Routh, A. (2020). Understanding Flavivirus Capsid Protein Functions: The Tip of the Iceberg. Pathogens, 9.","DOI":"10.3390\/pathogens9010042"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2014.03.014","article-title":"Amodiaquine, an Antimalarial Drug, Inhibits Dengue Virus Type 2 Replication and Infectivity","volume":"106","author":"Boonyasuppayakorn","year":"2014","journal-title":"Antivir. Res."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2014.09.007","article-title":"Antiviral Activity of Lanatoside C against Dengue Virus Infection","volume":"111","author":"Cheung","year":"2014","journal-title":"Antivir. Res."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.antiviral.2016.04.014","article-title":"Novel Antiviral Activity of Bromocriptine against Dengue Virus Replication","volume":"131","author":"Kato","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_259","doi-asserted-by":"crossref","unstructured":"Zakaria, M.K., Carletti, T., and Marcello, A. (2018). Cellular Targets for the Treatment of Flavivirus Infections. Front. Cell Infect. Microbiol., 8.","DOI":"10.3389\/fcimb.2018.00398"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.stem.2017.06.017","article-title":"High-Content Screening in HPSC-Neural Progenitors Identifies Drug Candidates That Inhibit Zika Virus Infection in Fetal-like Organoids and Adult Brain","volume":"21","author":"Zhou","year":"2017","journal-title":"Cell Stem Cell"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1128\/JVI.02091-10","article-title":"Insertion of MicroRNA Targets into the Flavivirus Genome Alters Its Highly Neurovirulent Phenotype","volume":"85","author":"Heiss","year":"2011","journal-title":"J. Virol."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1128\/JVI.07125-11","article-title":"MicroRNA Targeting of Neurotropic Flavivirus: Effective Control of Virus Escape and Reversion to Neurovirulent Phenotype","volume":"86","author":"Heiss","year":"2012","journal-title":"J. Virol."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"5915","DOI":"10.1016\/j.vaccine.2011.09.102","article-title":"Neurovirulent Flavivirus Can Be Attenuated in Mice by Incorporation of Neuron-Specific MicroRNA Recognition Elements into Viral Genome","volume":"31","author":"Yen","year":"2013","journal-title":"Vaccine"},{"key":"ref_264","doi-asserted-by":"crossref","unstructured":"Berzal-Herranz, A., Berzal-Herranz, B., Ramos-Lorente, S.E., and Romero-L\u00f3pez, C. (2022). The Genomic 3\u2032 UTR of Flaviviruses Is a Translation Initiation Enhancer. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158604"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.virusres.2009.02.016","article-title":"RNA Secondary Structures in the Proximal 3\u2032UTR of Indonesian Dengue 1 Virus Strains","volume":"142","author":"Koraka","year":"2009","journal-title":"Virus Res."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"622","DOI":"10.6026\/97320630009622","article-title":"Comparison of Full-Length Genomics Sequences between Dengue Virus Serotype 3, Parental Strain, and Its Derivatives, and B-Cell Epitopes Prediction from Envelope Region","volume":"9","author":"Thaisonthi","year":"2013","journal-title":"Bioinformation"},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4269\/ajtmh.2009.08-0595","article-title":"Translational Regulation by the 3\u2032 Untranslated Region of the Dengue Type 2 Virus Genome","volume":"81","author":"Zhao","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1016\/j.vaccine.2016.08.063","article-title":"MicroRNA Reduction of Neuronal West Nile Virus Replication Attenuates and Affords a Protective Immune Response in Mice","volume":"34","author":"Brostoff","year":"2016","journal-title":"Vaccine"},{"key":"ref_269","doi-asserted-by":"crossref","unstructured":"Avila-Bonilla, R.G., and Salas-Benito, J.S. (2022). Interactions of Host MiRNAs in the Flavivirus 3\u2019UTR Genome: From Bioinformatics Predictions to Practical Approaches. Front. Cell Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.976843"},{"key":"ref_270","unstructured":"(2023, September 01). Safety Study of Dengushield in Healthy Adults-Full Text View-ClinicalTrials.Gov, Available online: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03883620."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1056\/NEJMoa2000226","article-title":"Phase 1 Trial of a Therapeutic Anti\u2013Yellow Fever Virus Human Antibody","volume":"383","author":"Low","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_272","unstructured":"(2023, September 01). Safety and Tolerability of an Antibody against Zika Virus (Tyzivumab) in ZIKV Infected Patients-Full Text View-ClinicalTrials.Gov, Available online: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03776695."},{"key":"ref_273","unstructured":"(2023, September 01). Safety and Tolerability of an Antibody against Zika Virus (Tyzivumab) in Humans-Full Text View-ClinicalTrials.Gov, Available online: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03443830."},{"key":"ref_274","doi-asserted-by":"crossref","unstructured":"Rayamajhi, A., Nightingale, S., Bhatta, N.K., Singh, R., Ledger, E., Bista, K.P., Lewthwaite, P., Mahaseth, C., Turtle, L., and Robinson, J.S. (2015). A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0122608"},{"key":"ref_275","unstructured":"(2023, September 01). Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection-Full Text View-ClinicalTrials.Gov, Available online: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04267809."},{"key":"ref_276","unstructured":"(2023, September 01). WO2018165720A1-Agents for Treating or Preventing Viral Infections and Uses Therefor-Google Patents. Available online: https:\/\/patents.google.com\/patent\/WO2018165720A1\/en."},{"key":"ref_277","doi-asserted-by":"crossref","unstructured":"Croci, R., Bottaro, E., Chan, K.W.K., Watanabe, S., Pezzullo, M., Mastrangelo, E., and Nastruzzi, C. (2016). Liposomal Systems as Nanocarriers for the Antiviral Agent Ivermectin. Int. J. Biomater., 2016.","DOI":"10.1155\/2016\/8043983"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.antiviral.2013.06.002","article-title":"Nuclear Localization of Dengue Virus (DENV) 1-4 Non-Structural Protein 5; Protection against All 4 DENV Serotypes by the Inhibitor Ivermectin","volume":"99","author":"Tay","year":"2013","journal-title":"Antivir. Res."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.virusres.2018.11.016","article-title":"In Vitro Analysis of Synthetic Peptides in Blocking the Entry of Dengue Virus","volume":"260","author":"John","year":"2019","journal-title":"Virus Res."},{"key":"ref_280","doi-asserted-by":"crossref","unstructured":"Fumagalli, M.J., Figueiredo, L.T.M., and Aquino, V.H. (2021). Linear and Continuous Flavivirus Epitopes From Naturally Infected Humans. Front. Cell Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.710551"},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(03)14570-9","article-title":"Determinants of Survival Following HIV-1 Seroconversion after the Introduction of HAART","volume":"362","author":"Porter","year":"2003","journal-title":"Lancet"},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4155\/tde-2021-0079","article-title":"Antiviral Monoclonal Antibody Cocktails as a Modern Weapon in Combating Pandemics","volume":"13","author":"Liu","year":"2021","journal-title":"Ther. Deliv."},{"key":"ref_283","doi-asserted-by":"crossref","unstructured":"Kainov, D., and Oksenych, V. (2022). Broad-Spectrum Antivirals and Antiviral Combinations: An Editorial Update. Viruses, 14.","DOI":"10.3390\/v14102252"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7861\/clinmedicine.19-2-149","article-title":"Global Warming and Arboviral Infections","volume":"19","author":"Whitehorn","year":"2019","journal-title":"Clin. Med."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/11\/10\/2427\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:00:43Z","timestamp":1760130043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/11\/10\/2427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":284,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["microorganisms11102427"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms11102427","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]}}}